Angiotensin II enhances beta-adrenergic receptor-mediated vasorelaxation in aortas from young but not old rats.
Publication/Presentation Date
12-1-2000
Abstract
beta-Adrenergic receptor (beta-AR)-mediated (cAMP-dependent) vasorelaxation declines with advancing age. It has been shown that angiotensin II (ANG II), a potent vasoconstrictor, enhances cAMP-mediated vasorelaxation. Therefore, we questioned whether ANG II could reverse age-related, impaired beta-AR-mediated vasorelaxation and cAMP production. Pretreatment of aortic rings from 6-wk-old or 6-mo-old male Fischer 344 rats with ANG II significantly enhanced vasorelaxation induced by isoproterenol (Iso), a beta-AR agonist, and forskolin, a direct activator of adenylyl cyclase, but not dibutyryl-cAMP or isobutylmethylxanthine. The ANG II effect was blocked by losartan but not PD-123319 and was not observed in the aortas from 12- and 24-mo-old animals. Iso-stimulated cAMP production in the aorta was enhanced in the presence of ANG II in the 6-wk-old and 6-mo-old age groups only. Results suggest ANG II cannot reverse the age-related impairment in beta-AR-dependent vasorelaxation. We conclude aging may affect a factor common to both ANG II-receptors and beta-AR signaling pathways or aging may impair cross-talk between these two receptor pathways.
Volume
279
Issue
6
First Page
2807
Last Page
2814
ISSN
0363-6135
Published In/Presented At
Schutzer, W. E., Xue, H., Reed, J. F., Roullet, J. B., Anderson, S., & Mader, S. L. (2000). Angiotensin II enhances beta-adrenergic receptor-mediated vasorelaxation in aortas from young but not old rats. American journal of physiology. Heart and circulatory physiology, 279(6), H2807–H2814. https://doi.org/10.1152/ajpheart.2000.279.6.H2807
Disciplines
Medicine and Health Sciences
PubMedID
11087235
Department(s)
Department of Medicine
Document Type
Article